Ependymoma
"Ependymoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glioma derived from EPENDYMOGLIAL CELLS that tend to present as malignant intracranial tumors in children and as benign intraspinal neoplasms in adults. It may arise from any level of the ventricular system or central canal of the spinal cord. Intracranial ependymomas most frequently originate in the FOURTH VENTRICLE and histologically are densely cellular tumors which may contain ependymal tubules and perivascular pseudorosettes. Spinal ependymomas are usually benign papillary or myxopapillary tumors. (From DeVita et al., Principles and Practice of Oncology, 5th ed, p2018; Escourolle et al., Manual of Basic Neuropathology, 2nd ed, pp28-9)
Descriptor ID |
D004806
|
MeSH Number(s) |
C04.557.465.625.600.380.290 C04.557.470.670.380.290 C04.557.580.625.600.380.290
|
Concept/Terms |
Ependymoma, Papillary- Ependymoma, Papillary
- Ependymomas, Papillary
- Papillary Ependymomas
- Papillary Ependymoma
Ependymoma, Myxopapillary- Ependymoma, Myxopapillary
- Ependymomas, Myxopapillary
- Myxopapillary Ependymoma
- Myxopapillary Ependymomas
Anaplastic Ependymoma- Anaplastic Ependymoma
- Anaplastic Ependymomas
- Ependymoma, Anaplastic
- Ependymomas, Anaplastic
|
Below are MeSH descriptors whose meaning is more general than "Ependymoma".
Below are MeSH descriptors whose meaning is more specific than "Ependymoma".
This graph shows the total number of publications written about "Ependymoma" by people in this website by year, and whether "Ependymoma" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 | 1997 | 1 | 0 | 1 | 1998 | 1 | 0 | 1 | 1999 | 2 | 1 | 3 | 2000 | 1 | 0 | 1 | 2001 | 1 | 0 | 1 | 2003 | 1 | 0 | 1 | 2005 | 0 | 1 | 1 | 2006 | 1 | 0 | 1 | 2009 | 4 | 0 | 4 | 2013 | 1 | 1 | 2 | 2014 | 1 | 0 | 1 | 2015 | 3 | 0 | 3 | 2016 | 2 | 0 | 2 | 2017 | 3 | 0 | 3 | 2018 | 2 | 0 | 2 | 2019 | 3 | 0 | 3 | 2020 | 2 | 1 | 3 | 2021 | 5 | 0 | 5 | 2022 | 4 | 0 | 4 | 2023 | 6 | 0 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Ependymoma" by people in Profiles.
-
Donson AM, Bertrand KC, Riemondy KA, Gao D, Zhuang Y, Sanford B, Norris GA, Chapman RJ, Fu R, Willard N, Griesinger AM, Ribeiro de Sousa G, Amani V, Grimaldo E, Hankinson TC, Booker F, Sill M, Grundy RG, Pajtler KW, Ellison DW, Foreman NK, Ritzmann TA. Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study. Neuro Oncol. 2023 10 03; 25(10):1854-1867.
-
Okonechnikov K, Joshi P, Sepp M, Leiss K, Sarropoulos I, Murat F, Sill M, Beck P, Chan KC, Korshunov A, Sah F, Deng MY, Sturm D, DeSisto J, Donson AM, Foreman NK, Green AL, Robinson G, Orr BA, Gao Q, Darrow E, Hadley JL, Northcott PA, Gojo J, Kawauchi D, Hovestadt V, Filbin MG, von Deimling A, Zuckermann M, Pajtler KW, Kool M, Jones DTW, J?ger N, Kutscher LM, Kaessmann H, Pfister SM. Mapping pediatric brain tumors to their origins in the developing cerebellum. Neuro Oncol. 2023 10 03; 25(10):1895-1909.
-
Chee K, Chatain GP, Kortz MW, Serva S, Shrestha K, Ung TH, Witt JP, Finn M. Neurologic outcomes for adult spinal cord ependymomas stratified by tumor location: a retrospective cohort study and 2-year outlook. Neurosurg Rev. 2023 Sep 29; 46(1):258.
-
Chatzopoulos K, Hytiroglou P, Charville GW, Toland AMS, Martinez-Lage M, Cimino PJ, Rosenblum MK, Linos K. When a dermatopathologist encounters the ultra-rare: A case series of superficial soft tissue/cutaneous myxopapillary ependymomas. J Cutan Pathol. 2024 Jan; 51(1):20-29.
-
de Sousa GR, Salom?o KB, Nagano LFP, Riemondy KA, Chagas PS, Veronez LC, Saggioro FP, Marie SKN, Yunes JA, Cardinalli IA, Brandalise SR, de Paula Queiroz RG, Scrideli CA, Donson AM, Foreman NK, Tone LG, Valera ET. Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas. Cancer Gene Ther. 2023 08; 30(8):1105-1113.
-
Fu R, Norris GA, Willard N, Griesinger AM, Riemondy KA, Amani V, Grimaldo E, Harris F, Hankinson TC, Mitra S, Ritzmann TA, Grundy RR, Foreman NK, Donson AM. Spatial transcriptomic analysis delineates epithelial and mesenchymal subpopulations and transition stages in childhood ependymoma. Neuro Oncol. 2023 04 06; 25(4):786-798.
-
Lindsay HB, Massimino M, Avula S, Stivaros S, Grundy R, Metrock K, Bhatia A, Fern?ndez-Teijeiro A, Chiapparini L, Bennett J, Wright K, Hoffman LM, Smith A, Pajtler KW, Poussaint TY, Warren KE, Foreman NK, Mirsky DM. Response assessment in paediatric intracranial ependymoma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. Lancet Oncol. 2022 08; 23(8):e393-e401.
-
Greer HR, Miller K, Samay S, Nellan A, Green AL. Investigation of white blood cell characteristics in cerebrospinal fluid samples at pediatric brain tumor diagnosis. J Neurooncol. 2022 Sep; 159(2):301-308.
-
Foreman NK. Outcomes after first relapse of children with intracranial ependymoma treated on the second l'Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) protocol. Neuro Oncol. 2022 03 12; 24(3):480-481.
-
Hart M, Anderson-Mellies A, Beltrami A, Gilani A, Green AL. Population-based analysis of CNS tumor diagnoses, treatment, and survival in congenital and infant age groups. J Neurooncol. 2022 Apr; 157(2):333-344.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|